Gilenya is the first FDA-approved drug for the treatment of multiple sclerosis (MS) in pediatric patients. Earlier it was approved in 2010 to treat adult patients with relapsing MS.
You have read of your 8 free articles this month.
Subscribe to
Medgenera All-Access
Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.
Access articles & resources worth up to US $4, 000 per month.
Register with your email to read the full article.
This article is FREE for you! Unlock the unlimited access by subscribing to Medgenera All-Access.
More in DRUG TRIAL
DRUG TRIAL
FDA Approves First Therapy ‘Gilenya’ for Children with Multiple Sclerosis
Gilenya is the first FDA-approved drug for the treatment of multiple sclerosis (MS) in pediatric patients. Earlier it was approved in 2010 to treat adult patients with relapsing MS.
Most Popular
GROW
7 New Ideas to Start a Healthcare Business in India (2018)
Seven new #healthcare #business ideas in India in 2018. Which one would you prefer to pursue?
NEWLY PUBLISHED
Pharma Patents: Can India Reward Incremental Innovation?
Leave a reply